University of California, San Francisco
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Francisco sits in the top decile of US sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count).
University of California, San Francisco: 1,713 sponsored US clinical trials, 272 recruiting.
University of California, San Francisco sponsors 1,713 registered US clinical trials on ClinicalTrials.gov, 272 of them currently recruiting, and 1,130 completed. 196 of these trials are in Phase 3-4 (later-stage) and 359 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 18 trials.
Top-decile sponsor footprint
University of California, San Francisco ranks in the top decile of sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,130 of 1,305 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,713 total, page 25 of 35
Two Methods of Diagnosing Preterm Labor
NCT01431885
Maternal, Adiposity, Metabolism, and Stress Study
NCT01307683
Shared Decision Making in Patients With Osteoarthritis of the Hip and Knee
NCT01492257
Healthy Mood Internet Intervention Research Project
NCT01358487
Breast Cancer Risk Reduction: A Patient Doctor Intervention
NCT01830933
Magnetic Resonance Guided Focused Ultrasound for Uterine Fibroids
NCT01377519
Investigating the Impact of Tamoxifen Therapy on Ovarian Aging
NCT01384526
Glass Ionomer Sealant and Fluoride Varnish Study to Prevent Early Childhood Caries
NCT01129440
Preventing Loss of Independence Through Exercise (PLIÉ) - Pilot
NCT01371214
Reducing Immunization Distress (RID)
NCT01379885
Effects of Sleep Duration and Architecture on Insulin Sensitivity
NCT01396941
Development and Pilot Test of an Elective Bilateral Salpingo-Oophorectomy (BSO) Decision Support Guide
NCT01369654
Cluster, Randomized Trial on Long Acting Reversible Contraception (LARC) Education and Training
NCT01360216
HIV Screening Take-up: Evaluating Incentives and Opt-out Strategies
NCT01377857
Tobacco Intervention in Buprenorphine Treatment
NCT01350011
Study of Medical Assistant Health Coaching in Primary Care for Patients With Chronic Conditions
NCT01220336
The Effects of Omega-3 Fatty Acids Supplementation on Endothelial Function and Inflammation
NCT01310270
Dyad Oxytocin Study (DOS)
NCT02302209
Placebo-Controlled Cross Over Trial of Chlorzoxazone Intake
NCT01342341
RCT: Can a Single Counseling Phone Call Improve Contraception After an Abortion?
NCT01199952
Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)
NCT01276236
MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies
NCT01235897
The Effect of Problem Solving Therapy and Antidepressant Therapy on Cerebral Perfusion and Brain Derived Neurotropic Factor (BDNF) in Depressed Elders
NCT01305889
High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed Neuroblastoma
NCT01313936
Childhood Anesthesia and Cognitive Function
NCT01359215
Study of the Ability of Betaine Hydrochloride to Increase Stomach Acid in Healthy Volunteers
NCT01237353
Fear of Recurrence Pilot Intervention for Women With Breast Cancer
NCT01354041
Nuevo Amanecer: Promoting the Psychosocial Health of Latinas
NCT01383174
A Randomized Controlled Trial of the Bruthas Project
NCT01270230
Applying Mobile Persuasive Technologies to Increase Physical Activity in Women
NCT01280812
Impact of Physical Activity on Left Ventricular Mass and Lipid Metabolism
NCT01199211
4 Repeat Tauopathy Neuroimaging Initiative
NCT01804452
Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation
NCT01316549
Pilot Trial of CenteringPregnancy With Mindfulness Skills
NCT01646463
Comparing (SIS.NET) to Standard Care in Patients Who Have Completed the Acute Phase of Treatment for Early Breast Cancer
NCT01308775
Short-term Disulfiram Administration to Accelerate the Decay of the HIV Reservoir in Antiretroviral-treated HIV Infected Individuals
NCT01286259
Mindfulness Based Tinnitus Reduction (MBTR): A Symptom Perception Shift Program
NCT01229709
Is Fructose Linked to Adiposity in Babies?
NCT01262781
Pilot Study of Avoidance of Bladder Catheters in Stroke Patients to Avoid Urinary Tract Infections
NCT01275261
Cellular Aging and Neurobiology of Depression Study
NCT00285935
Dexamethasone Infusion to the Adventitia to Enhance Clinical Efficacy After Femoropopliteal Revascularization
NCT01507558
Long-term Caloric Restriction and Cellular Aging Markers
NCT01256840
Seven Year Update of Macular Degeneration Patients
NCT01256827
Study of Sleep and Delirium in the Intensive Care Unit (ICU)
NCT01280097
The Effect of General Anesthesia on the Risk for Arrhythmia
NCT01174251
The Effect of 16 Weeks of Hip Adduction and Abduction Resistance Exercise
NCT01228877
Dexmedetomidine in Seizure Patients
NCT01116700
T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal Tregs
NCT01210664
Transseptal Needle Versus Radiofrequency Energy for Left Atrial Access
NCT01209260
Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer
NCT01229618
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 166 |
| Phase 3 | 44 |
| Phase 4 | 152 |
Therapeutic Areas
What is open in the University of California, San Francisco pipeline
272 recruiting of 1,713 indexed (16% open); 1,130 completed (66%).
Phase mix: 196 late (III/IV) vs 359 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (18 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Francisco: open-pipeline peers nationwide
Peers matched on 1,713 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of California, San Francisco sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,713 trials (± recruiting share)
- Duke University · 1,725 trials · 11% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 16% open enrollment (± trial volume)
- University of Oregon · 16% recruiting · 63 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- Youngstown State University · 16% recruiting · 19 trials
- ECOG-ACRIN Cancer Research Group · 16% recruiting · 75 trials
Related
What to do with this University of California, San Francisco page
1,713 registered trials is a research-attention snapshot, not an endorsement of University of California, San Francisco or any single study.
- 272 of University of California, San Francisco's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition University of California, San Francisco studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Francisco pipeline card: 1,713 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.